ribavirin has been researched along with Lung Diseases, Interstitial in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Hirose, K; Honma, T; Ishikawa, T; Kamimura, T; Kubota, T; Nagashima, A; Seki, K; Togashi, T; Yoshida, T | 1 |
| Andreone, P; Brown, KK; Cammarata, S; Chuang, WL; Feutren, G; Flisiak, R; Foster, GR; George, J; Gould, M; Jacobson, IM; Komolmit, P; Lee, CM; Messina, I; Pianko, S; Piratvisuth, T; Rasenack, J; Sarin, SK; Shah, S; Sola, R; Sood, A; Tanwandee, T; Thongsawat, S; Yin, Y; Zeuzem, S | 1 |
| Baron, J; Biedroń-Machura, M; Błońska-Fajfrowska, B; Musialik, J; Pierzchała, W; Sozańska, E; Zbroszczyk, M | 1 |
| George, PM; Mitchell, JA | 1 |
| Adachi, K; Hayashi, M; Ishii, T; Kumano, R; Kumon, D; Sato, A; Yamada, T; Yamauchi, M | 1 |
| Jiao, J; Liu, W; Qu, C; Zheng, Z; Zhu, J | 1 |
| Diego, R; Giampaolo, Q; Marco, R; Sara, B; Vasilij Benatti, S | 1 |
| Okubo, A; Tamaki, K | 1 |
| Drenth, JP; Heijdra, YF; Slavenburg, S | 1 |
| Kim, SJ; Kornek, M; Schuppan, D; Shimada, M; Yoshida, S | 1 |
| Bode, JC; Rothfuss, KS | 1 |
| Abi-Nassif, S; Fogel, RB; Hallisey, RK; Mark, EJ | 1 |
| Beissner, R; Carpenter, J; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
| Bertrand, JJ; Germain, S; Halfon, P; Harafa, A; Larroque, O; Martin, S; Muller, P; Renou, C | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
| Fibbe, WE; Kroes, AC; van Dissel, JT; Zijlmans, JM | 1 |
| Konno, K; Mori, S; Shigeta, S; Sudo, K; Watanabe, W; Yokota, T | 1 |
| Ahmed, S; Karim, A; Khan, A; Mattana, J; Steinberg, H | 1 |
2 review(s) available for ribavirin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases, Interstitial; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.
Topics: Aged; Antiviral Agents; Female; Granuloma; Hepatitis C; Humans; Interferons; Lung Diseases, Interstitial; Ribavirin | 2004 |
1 trial(s) available for ribavirin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
Topics: Adult; Albumins; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Polyethylene Glycols; Pulmonary Diffusing Capacity; Radiography, Thoracic; Recombinant Proteins; Ribavirin; Spirometry | 2013 |
17 other study(ies) available for ribavirin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Early Diagnosis; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases, Interstitial; Male; Middle Aged; Mucin-1; Polyethylene Glycols; Predictive Value of Tests; Pulmonary Surfactant-Associated Protein D; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome | 2012 |
[Respiratory function impairment during treatment of chronic hepatitis C with peginterferon alfa2 and ribavirin. Two cases presentation].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lung Diseases, Interstitial; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Young Adult | 2012 |
Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virus.
Topics: Albumins; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lung; Lung Diseases, Interstitial; Male; Polyethylene Glycols; Ribavirin | 2013 |
Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.
Topics: Antiviral Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Lung Diseases, Interstitial; Middle Aged; Remission Induction; Ribavirin | 2014 |
A case of chronic hepatitis C patient of myocardial ischemia accompanied with interstitial pneumonia induced by pegylated interferon alpha-2a.
Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lung Diseases, Interstitial; Middle Aged; Myocardial Ischemia; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2014 |
Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
Topics: Adult; Antiviral Agents; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension, Pulmonary; Interferon-alpha; Lung Diseases, Interstitial; Male; Middle Aged; Ribavirin | 2014 |
Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interferon-alpha; Lung Diseases, Interstitial; Polyethylene Glycols; Prednisolone; Recombinant Proteins; Ribavirin; Simeprevir; Sulfonamides; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
Topics: Antiviral Agents; Drug Substitution; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases, Interstitial; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Viral Load | 2010 |
Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C.
Topics: Antiviral Agents; Blood Sedimentation; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases, Interstitial; Middle Aged; Recombinant Proteins; Ribavirin; Tomography, X-Ray Computed | 2002 |
Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
Topics: Antiviral Agents; Biopsy; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Polyethylene Glycols; Radiography; Recombinant Proteins; Respiratory Distress Syndrome; Ribavirin | 2003 |
Interstitial pneumonia recurrence during chronic hepatitis C treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases, Interstitial; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Tomography, X-Ray Computed | 2005 |
Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Lung Diseases, Interstitial; Male; Middle Aged; Mucin-1; Mucins; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Retrospective Studies; Ribavirin | 2007 |
Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Humans; Lung Diseases, Interstitial; Male; Pneumonia, Viral; Radiography; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Seminoma; Testicular Neoplasms | 1995 |
From the Centers for Disease Control and Prevention. Update: hantavirus pulmonary syndrome--United States, 1993.
Topics: Bunyaviridae Infections; Clinical Trials as Topic; Fever; Humans; Lung Diseases, Interstitial; Orthohantavirus; Polymerase Chain Reaction; Pulmonary Edema; Respiratory Distress Syndrome; Ribavirin; Thrombocytopenia; United States | 1993 |
Update: hantavirus pulmonary syndrome--United States, 1993.
Topics: Adolescent; Adult; Aged; Bunyaviridae Infections; Child; Clinical Trials as Topic; Female; Fever; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Orthohantavirus; Polymerase Chain Reaction; Pulmonary Edema; Respiratory Distress Syndrome; Ribavirin; Thrombocytopenia; United States | 1993 |
Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo.
Topics: Animals; Antiviral Agents; Cyclophosphamide; Disease Models, Animal; Female; HeLa Cells; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Mice; Mice, Inbred BALB C; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin | 1999 |
Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon Type I; Lung Diseases, Interstitial; Male; Middle Aged; Recombinant Proteins; Ribavirin; Tomography, X-Ray Computed | 2001 |